Ipad and the cloud: Further roll out of digital health hub

Further roll out of digital health hub across England

A digital health hub piloted in Nailsea is being scaled up across England, as demand increases from councils in North West London, the Wirral,...
Liz Cross: Addressing antimicrobial resistance

Addressing antimicrobial resistance

Liz Cross, advanced nurse practitioner and non-medical prescriber, is taking huge steps in reducing the unnecessary prescribing of antibiotics to address antimicrobial resistance (AMR). What is your...

Lack of public awareness in choice of hospitals when accessing NHS treatment

A new poll by Populus has identified a lack of public awareness in choice of hospitals when accessing NHS treatment. Populus interviewed 6116 adults online...
link between Type 2 diabetes and cardiovascular disease risk

New research into the link between Type 2 diabetes and cardiovascular disease risk

New research into the link between Type 2 diabetes and cardiovascular disease risk highlights improvements in cardiovascular risk for women developing Type 2 diabetes...

The role of clinical pharmacists in primary and community care

The General Practitioners Committee of the British Medical Association’s longstanding ambition for every GP practice to benefit from having a pharmacist is now much...
Digital experts to join cancer and mental health teams

NHSX: digital experts to join cancer and mental health teams

Digital experts to join cancer and mental health teams as part of the growth of NHSX - a new joint organisation for digital, data...
link between Type 2 diabetes and cardiovascular disease risk

Virtual reality for doctors – preparing for diabetes emergencies

Virtual reality for doctors - How virtual reality can prepare doctors for diabetes emergencies The NHS England diabetes team has partnered with Oxford Medical Simulation...
The cost of prescriptions report from NHS Digital

The cost of prescriptions report published

The cost of prescriptions dispensed in the community and the number of items dispensed during the 2018 calendar year has been published by NHS...
Type 2 diabetes screening in community pharmacies

Type 2 diabetes screening in community pharmacies

Type 2 diabetes screening in community pharmacies could increase early diagnosis and reduce NHS costs, according to a new study. The study by Boots UK...
Brain scan image: Detecting and managing atrial fibrillation

Detecting and managing atrial fibrillation

The ‘Podiatry and Atrial Fibrillation – Save a life, stop a stroke’ webinar was created to improve the detection and management of atrial fibrillation,...

Latest articles

Dr Harry Destecroix of Ziylo wins 2019 Pharmaceutical Industry Network Group Innovation Award

Biotech leader wins PING Innovation Award 2019

Dr Harry Destecroix of Ziylo has won the 2019 Pharmaceutical Industry Network Group (PING) Innovation Award, hosted by pharma and life sciences specialist law...
NICE recommend funding for Spinraza

NICE recommend funding for Spinraza for spinal muscular atrophy

The National Institute for Health and Care Excellence (NICE) has recommended funding for Spinraza (nusinersen) on the National Health Service (NHS). The positive recommendation, subject to...
Data from Symbicort Turbuhaler Novel START trial among 73 AstraZeneca abstracts accepted for presentation at ATS

New data from Novel START trial accepted for presentation

New data from the Symbicort Turbuhaler (budesonide/formoterol) Novel START trial is among 73 AstraZeneca abstracts accepted for oral or poster presentation at the American...

Popular articles

pain relief patch released by nurofen

Nurofen launches a 24 hour ibuprofen pain relief patch

Nurofen announces the launch of the UK’s only 24 hour clinically proven pain relief patch containing ibuprofen.  Despite body pain being among the most commonly...
new migraine data for Aimovig presented by Novartis

Novartis presents new migraine data for Aimovig®▼ (erenumab)

Novartis presents new migraine data for Aimovig®▼ (erenumab) demonstrating sustained efficacy to 52 weeks. Novartis has announced that new data from two follow-up studies of...
Data from Symbicort Turbuhaler Novel START trial among 73 AstraZeneca abstracts accepted for presentation at ATS

New data from Novel START trial accepted for presentation

New data from the Symbicort Turbuhaler (budesonide/formoterol) Novel START trial is among 73 AstraZeneca abstracts accepted for oral or poster presentation at the American...

Top 5 R&D hubs in the UK

Read this cover story in the June issue of Pf Magazine here.    Join us on a tour of inspirational research and development centres. ...
Dr Harry Destecroix of Ziylo wins 2019 Pharmaceutical Industry Network Group Innovation Award

Biotech leader wins PING Innovation Award 2019

Dr Harry Destecroix of Ziylo has won the 2019 Pharmaceutical Industry Network Group (PING) Innovation Award, hosted by pharma and life sciences specialist law...